• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association of Germline Variation in Driver Genes with Breast Cancer Risk in Chilean Population.智利人群种系驱动基因突变与乳腺癌风险的关联。
Int J Mol Sci. 2023 Nov 8;24(22):16076. doi: 10.3390/ijms242216076.
2
Heritable genomic diversity in breast cancer driver genes and associations with risk in a Chilean population.遗传性基因组多样性在乳腺癌驱动基因中的作用及其与智利人群风险的关联。
Biol Res. 2022 May 31;55(1):20. doi: 10.1186/s40659-022-00384-4.
3
Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.摩洛哥研究人群中APOBEC3和驱动基因的功能性种系变异对乳腺癌风险的分析。
BMC Cancer. 2016 Feb 26;16:165. doi: 10.1186/s12885-016-2210-8.
4
Germline Variants in Driver Genes of Breast Cancer and Their Association with Familial and Early-Onset Breast Cancer Risk in a Chilean Population.智利人群中乳腺癌驱动基因的种系变异及其与家族性和早发性乳腺癌风险的关联
Cancers (Basel). 2020 Jan 20;12(1):249. doi: 10.3390/cancers12010249.
5
Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.FGFR2 和 MAP3K1 中的遗传变异与南美人种家族性和早发性乳腺癌的风险相关。
Breast Cancer Res Treat. 2013 Jan;137(2):559-69. doi: 10.1007/s10549-012-2359-z. Epub 2012 Dec 7.
6
Functional germline variants in driver genes of breast cancer.乳腺癌驱动基因中的功能性种系变异
Cancer Causes Control. 2017 Apr;28(4):259-271. doi: 10.1007/s10552-017-0849-3. Epub 2017 Feb 25.
7
Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.乳腺癌/卵巢癌患者中新型及复发性BRCA1/BRCA2种系突变:来自突尼斯南部的系列研究
J Transl Med. 2021 Mar 16;19(1):108. doi: 10.1186/s12967-021-02772-y.
8
New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients.图瓦蒙古族乳腺癌患者中新的胚系 BRCA2 基因突变。
Mol Biol Rep. 2019 Oct;46(5):5537-5541. doi: 10.1007/s11033-019-04928-y. Epub 2019 Jul 4.
9
Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer.FANCM 基因内功能丧失性突变与早发性家族性乳腺癌的关联。
JAMA Oncol. 2017 Sep 1;3(9):1245-1248. doi: 10.1001/jamaoncol.2016.5592.
10
BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.BRCA1 和 BRCA2 未分类变异体及错义多态性在阿尔及利亚乳腺癌/卵巢癌家族中的研究。
Dis Markers. 2012;32(6):343-53. doi: 10.3233/DMA-2012-0893.

引用本文的文献

1
A contemporary review of breast cancer risk factors and the role of artificial intelligence.乳腺癌风险因素及人工智能作用的当代综述
Front Oncol. 2024 Apr 18;14:1356014. doi: 10.3389/fonc.2024.1356014. eCollection 2024.

本文引用的文献

1
MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer.丝裂原活化蛋白激酶激酶激酶1(MAP3K1)的表达与激素受体阳性、人表皮生长因子受体2(HER2)阴性的早期乳腺癌的进展及不良预后相关。
Cell Oncol (Dordr). 2023 Oct;46(5):1213-1234. doi: 10.1007/s13402-023-00805-w. Epub 2023 May 11.
2
Global Burden of Female Breast Cancer: Age-Period-Cohort Analysis of Incidence Trends From 1990 to 2019 and Forecasts for 2035.全球女性乳腺癌负担:1990年至2019年发病率趋势的年龄-时期-队列分析及2035年预测
Front Oncol. 2022 Jun 9;12:891824. doi: 10.3389/fonc.2022.891824. eCollection 2022.
3
MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types.MAP3K 家族综述及其与多种癌症类型患者生存结局的相关性。
Front Biosci (Landmark Ed). 2022 May 23;27(5):167. doi: 10.31083/j.fbl2705167.
4
Heritable genomic diversity in breast cancer driver genes and associations with risk in a Chilean population.遗传性基因组多样性在乳腺癌驱动基因中的作用及其与智利人群风险的关联。
Biol Res. 2022 May 31;55(1):20. doi: 10.1186/s40659-022-00384-4.
5
BRCA1 and BRCA2 screening of nine Chilean founder mutations through allelic-discrimination and real-time PCR in breast/ovarian cancer patients.对 9 种智利种系突变进行 BRCA1 和 BRCA2 筛查,采用等位基因鉴别和实时 PCR 方法,检测乳腺癌/卵巢癌患者。
Mol Biol Rep. 2022 Aug;49(8):7531-7539. doi: 10.1007/s11033-022-07561-4. Epub 2022 May 21.
6
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants.通过综合组织学、免疫组织化学和分子方法诊断幼年性息肉病,发现新的 SMAD4 致病性变异。
Fam Cancer. 2022 Oct;21(4):441-451. doi: 10.1007/s10689-022-00289-x. Epub 2022 Jan 25.
7
Spectrum of mutations in breast cancer is luminal subtype-predominant and related to prognosis.乳腺癌中的基因突变谱以管腔亚型为主且与预后相关。
Oncol Lett. 2022 Feb;23(2):68. doi: 10.3892/ol.2022.13187. Epub 2022 Jan 3.
8
Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung Cancer.转化生长因子-β1通路中的基因变异可能会提高非小细胞肺癌总生存期的预测能力。
Front Oncol. 2021 Jul 7;11:599719. doi: 10.3389/fonc.2021.599719. eCollection 2021.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
A compendium of mutational cancer driver genes.癌症驱动基因突变综合分析
Nat Rev Cancer. 2020 Oct;20(10):555-572. doi: 10.1038/s41568-020-0290-x. Epub 2020 Aug 10.

智利人群种系驱动基因突变与乳腺癌风险的关联。

Association of Germline Variation in Driver Genes with Breast Cancer Risk in Chilean Population.

机构信息

Centro de Oncología de Precisión (COP), Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, Las Condes, Santiago 7560908, Chile.

Laboratorio de Transformación Celular, Programa de Biología Celular y Molecular, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia, Santiago 783090, Chile.

出版信息

Int J Mol Sci. 2023 Nov 8;24(22):16076. doi: 10.3390/ijms242216076.

DOI:10.3390/ijms242216076
PMID:38003265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10671568/
Abstract

Cancer is a genomic disease, with driver mutations contributing to tumorigenesis. These potentially heritable variants influence risk and underlie familial breast cancer (BC). This study evaluated associations between BC risk and 13 SNPs in driver genes , , , , , , , , and , in -negative Chilean families. SNPs were genotyped using TaqMan Assay in 492 cases and 1285 controls. There were no associations between rs75704921:C>T (); rs2229032:A>C (); rs3735156:C>G (); rs2276738:G>C, rs2293906:C>T, rs4075943T:>A, rs13091808:C>T (); rs178831:G>A (); or rs3759173:C>A () and risk. The rs832583 A allele (C/A+A/A) showed a protective effect in families with moderate BC history (OR = 0.7 [95% CI 0.5-0.9] = 0.01). rs16865677-T (G/T+T/T) increased risk in sporadic early-onset BC (OR = 1.4 [95% CI 1.0-2.0] = 0.01). rs3819122-C (A/C+C/C) increased risk in cases with moderate family history (OR = 2.0 [95% CI 1.3-2.9] ≤ 0.0001) and sporadic cases diagnosed ≤50 years (OR = 1.6 [95% CI 1.1-2.2] = 0.006). rs12456284:A>G increased BC risk in G-allele carriers (A/G + G/G) in cases with ≥2 BC/OC cases and early-onset cases (OR = 1.2 [95% CI 1.0-1.6] = 0.04 and OR = 1.4 [95% CI 1.0-1.9] = 0.03, respectively). Our study suggests that specific germline variants in driver genes , , and contribute to BC risk in Chilean population.

摘要

癌症是一种基因组疾病,驱动突变导致肿瘤发生。这些潜在的可遗传变异影响风险,并构成家族性乳腺癌(BC)的基础。本研究评估了 13 个驱动基因中的 SNPs 与 BC 风险之间的关联,这些基因包括、、、、、、、和,在智利无家族史的阴性家族中。在 492 例病例和 1285 例对照中,使用 TaqMan 分析进行了 SNPs 基因分型。rs75704921:C>T();rs2229032:A>C();rs3735156:C>G();rs2276738:G>C,rs2293906:C>T,rs4075943:T:>A,rs13091808:C>T();rs178831:G>A();或 rs3759173:C>A()与风险无关。rs832583 的 A 等位基因(C/A+A/A)在具有中度 BC 病史的家族中表现出保护作用(OR=0.7 [95%CI 0.5-0.9] = 0.01)。rs16865677-T(G/T+T/T)增加了散发性早发性 BC 的风险(OR=1.4 [95%CI 1.0-2.0] = 0.01)。rs3819122-C(A/C+C/C)增加了中度家族史病例的风险(OR=2.0 [95%CI 1.3-2.9] ≤ 0.0001)和散发性病例诊断≤50 岁(OR=1.6 [95%CI 1.1-2.2] = 0.006)。rs12456284:A>G 增加了携带 G 等位基因的病例(A/G+G/G)的 BC 风险,这些病例具有≥2 例 BC/OC 病例和早发性病例(OR=1.2 [95%CI 1.0-1.6] = 0.04 和 OR=1.4 [95%CI 1.0-1.9] = 0.03)。本研究表明,智利人群中特定的驱动基因中的种系变体、和有助于 BC 风险。